Plus Library

Displaying 1,026 - 1,050 of 2,875

Lymphoma: State of the Art
Lymphoma: State of the Art
Alexey Danilov, MD, PhD
Lymphoma: State of the Art
Lymphoma: State of the Art
Alexey Danilov, MD, PhD
Hematology Session III
Hematology Session III
Francine Foss, Eduardo Sotomayor, Nakhle Saba
T-Cell NHL: What’s New?
T-Cell NHL: What’s New?
Francine M. Foss, MD
CLL: Novel Therapies
CLL: Novel Therapies
Javier Pinilla-Ibarz, MD
Novel Therapies for Aggressive Non-Hodgkin Lymphomas
Novel Therapies for Aggressive Non-Hodgkin Lymphomas
Kami J. Maddocks, MD
Lymphoma and CLL 2024 Updates
Lymphoma and CLL 2024 Updates
Maxwell M. Krem, MD, PhD
Lymphoma and CLL 2024 Updates
Lymphoma and CLL 2024 Updates
Maxwell M. Krem, MD, PhD
Treatment of Patients Progressing after BTKi and BCL2i
Treatment of Patients Progressing after BTKi and BCL2i
Nitin Jain, MD
AML and MDS: New Directions
AML and MDS: New Directions
Olatoyosi Odenike, MD
AML and MDS: New Directions
AML and MDS: New Directions
Olatoyosi Odenike, MD
MDS: State of the Art
MDS: State of the Art
Paul Koller, MD
Hematology Session I
Hematology Session I
Rami Komrokji, Mohamed Kharfan-Dabaja, Guillermo Garcia-Manero
Hematology Session II
Hematology Session II
Sikander Ailawadhi, Javier Pinilla-Ibarz, Lisa Welsh